DNAnexus

The world’s most secure cloud platform and global network for scientific collaboration and accelerated discovery.

About

Founded

2009

Headquarters

Mountain View, California

Industry

Biotech

Company Description

DNAnexus combines expertise in cloud computing and bioinformatics to create the global network for genomic medicine. DNAnexus provides security, scalability, and collaboration for enterprises and organizations that are pursuing genomic-based approaches to health in order to accelerate medical discovery. DNAnexus is supporting customers around the world that are tackling some of the most challenging and exciting opportunities in human health.

Quick Links

WebsiteJobs

Funding

Total Raised

$472.6 million

Valuation

~$600 million+

Significant Investors

First Round Capital, Northpond Ventures, GV, Perceptive Advisors, Innovatus Capital Partners, Foresite Capital, Blackstone Growth, Claremont Creek Ventures

Company Traction

  • As of March 2022, DNAnexus has 12,000 users across 48 countries.
  • As of March 2022, DNAnexus counts 7/10 top pharmaceutical and 8/10 top diagnostics companies as customers.
  • As of March 2022, DNAnexus stores 65 petabytes of data, which is a 70% YoY growth since 2015.
  • As of May 2023, DNAnexus has 100+ enterprise customers and runs 100K+ jobs monthly.
  • DNAnexus customers include Intermountain Healthcare, Natera, and Eli Lilly.

Leadership Team

  • Richard Daly: CEO of DNAnexus.
  • Stephen Nuckols: Chief Commercial Officer at DNAnexus. Former CRO at ArisGlobal.
  • Kelly Green: Chief People Officer at DNAnexus. Former Senior Director, Human Resources Operations at Telenav.